Skip to content
  • BiotechReality JobFinder
  • Market Analysis
  • Publish on BiotechReality
  • linkedin
  • facebook
  • instagram
  • twitter
BiotechReality Home
BiotechReality – Information Intelligence System for Biopharma
  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
Popular
#Eli Lilly and Company #Johnson&Johnson #Clinical Data #Quarterly Results #FDA Approval #Phase 3 Trials #Novo Nordisk #Cancer

Category: News

Biotechnology News Toxicology

CRISPR technology paves the way for a new antidote for Cobra bites

  • By Editor's Desk
  • 19 July 2024
Cobra Snake Image

Every year, hundreds of individuals are killed by cobra venom, and an estimated 100,000 more suffer severe injuries from necrosis, which is the loss of bodily tissue and cells and can result in amputation.

Tagged Cobra Venom, CRISPR
Healthcare & Pharmaceuticals News Research

New antibody therapy to neutralize a wide variety of HIV-1 strains

  • By Editor's Desk
  • 19 July 2024
hiv antibody therapy

This new study offers a broadly useful technique to improve nanobodies’ performance. Artificially created antibody fragments, known as nanobodies, are around 10 times smaller than regular antibodies.

Tagged Antibody Therapy, HIV
Gene Therapy News Research

Researchers discovered a new Gene Therapy for muscular dystrophy

  • By Editor's Desk
  • 18 July 2024
gene editing tool

The protein dystrophin, absent in people with muscular dystrophy, will subsequently begin to be produced by the additional genetic code.

Tagged Gene Therapy, Muscular Dystrophy
Machine Learning News

New subtypes of Parkinson’s Disease can be defined by Machine Learning

  • By Editor's Desk
  • 17 July 2024
anti amyloid clinical trial alzheimer's drug

The different patterns of illness development that the subtypes exhibited allowed the investigators to identify them.

Tagged Machine Learning, Parkinson's disease
Genomics News

First identified in humans, CoRSIVs are now found in cattle

  • By Journal Updates
  • 17 July 2024
DNA Structure

CoRSIVs are sections of the genome that include chemical markers on their DNA. These markers may tell farmers things like milk output, female fertility, and disease resistance.

Tagged Cattles, CoRSIV, DNA, DNA Methylation
Research News

Research: A new neural biomarker for OCD

  • By Editor's Desk
  • 14 July 2024
alzheimer's treatments and therapies

Two to three per cent of people worldwide suffer from OCD, a prevalent and debilitating mental illness. OCD affects over two million people in the United States.

Tagged Neural Biomarker, OCD
Gene Therapy News Research

Cystic Fibrosis mutation in human lung cells corrected by Prime Editing

  • By Editor's Desk
  • 11 July 2024
cystic fibrosis in the lungs

Researchers at the University of Iowa, the Broad Institute of MIT, Harvard, and Harvard have now created a gene-editing method that effectively fixes the most prevalent mutation affecting 85% of patients

Tagged Cystic Fibrosis, Lungs
Immunology News

Discovery of new T cells and genes related to immune disorders

  • By Editor's Desk
  • 6 July 2024
detection of epilepsy

They discovered many subsets of uncommon T cell types, making up less than 5% of the total, after examining almost a million human T cells.

Tagged Genes, Immune Disorders, T cells
Astrobiology News Research

Phosphate findings in NASA’s OSIRIS-REx samples

  • By Editor's Desk
  • 29 June 2024
nasa asteroid bennu

Bennu is home to the primordial materials that gave rise to our solar system, according to the OSIRIS-REx Sample Analysis Team.

Tagged Biotechnology, OSIRIS-REx mission
Healthcare & Pharmaceuticals News Research

Advancement in research improves checkpoint inhibitor therapy for cancer

  • By Editor's Desk
  • 27 June 2024
gene expression regulation in cancer representation

Researchers at Scripps Research have recently discovered that when taken with checkpoint inhibitors, the immunosuppressive medication ruxolitinib, which is licenced, enhanced T-cell responses and increased the drugs’ ability to fight cancer.

Tagged Cancer, Cancer Therapy

Posts navigation

← Older Posts
→ Newer Posts
Advertisement

Areas Covered

  • Anti-obesity Drugs
  • Artificial Intelligence
  • Astrobiology
  • Autoimmune Diseases
  • Biochemistry
  • Bioengineering
  • Bioinformatics
  • Biologics
  • Biosimilars
  • Biostatistics
  • Biotechnology
  • Blog
  • Business
  • Cancer
  • CDMO
  • Cell Biology
  • Clinical Data
  • Clinical Investigation
  • Clinical Trials
  • Collection
  • CRDMO
  • CRO
  • Cybersecurity
  • Deep Learning
  • Diabetes
  • Diagnostic Tests
  • Disease Biology
  • Diseases
  • Drug Discovery
  • Drugs
  • Engineering
  • Epidemiology
  • Gene Therapy
  • General Biology
  • Genetics
  • Genomics
  • Healthcare & Pharmaceuticals
  • Immunology
  • Immunotherapy
  • Instrumentation
  • Laboratory Info
  • Legal and Patent Affairs
  • Life Sciences
  • Machine Learning
  • Manufacturing
  • Medical Devices
  • Mental Health
  • Merger & Acquisitions
  • Microbiology
  • Microscopy
  • Molecular Biology
  • Nanotechnology
  • Neuroscience
  • News
  • Oncology
  • Pharmacology
  • Rare Diseases
  • Regenerative Medicine
  • Regulatory
  • Regulatory Approval
  • Research
  • Science
  • Science Communication
  • Supply Chain
  • Technology
  • Therapies
  • Toxicology
  • Vaccines
  • Virology
  • Weight-loss Drugs

Discover More

Merck KGaA Q3 2026 Results: Pimjetmi FDA Approval and Silence Therapeutics Deal Back a Raised Full-Year Outlook
Business Life Sciences News

Merck KGaA Q3 2026 Results: Pimjetmi FDA Approval and Silence Therapeutics Deal Back a Raised Full-Year Outlook

12 November 202612 November 2026
BiotechReality Business Intelligence Desk
Novartis Rhapsido CIndU Data: Remibrutinib Shows Sustained Efficacy Through Week 52 in Phase III RemIND Study
Clinical Data Healthcare & Pharmaceuticals News

Novartis Rhapsido CIndU Data: Remibrutinib Shows Sustained Efficacy Through Week 52 in Phase III RemIND Study

12 November 202612 November 2026
Clinical Trials & Data Desk
Amgen Dazodalibep Phase 3 OASIZ-301 Results Show Systemic Disease Activity Gains in Sjögren’s Disease
Clinical Data Healthcare & Pharmaceuticals News Rare Diseases

Amgen Dazodalibep Phase 3 OASIZ-301 Results Show Systemic Disease Activity Gains in Sjögren’s Disease

12 November 202612 November 2026
Clinical Trials & Data Desk
Novo Nordisk World Diabetes Foundation Commitment: Pledges USD 200 Million for Diabetes Prevention and Care, 2027–2036
Diabetes Business Healthcare & Pharmaceuticals News

Novo Nordisk World Diabetes Foundation Commitment: Pledges USD 200 Million for Diabetes Prevention and Care, 2027–2036

11 November 202611 November 2026
BiotechReality Business Intelligence Desk
Charles River Frontage Acquisition: Charles River Laboratories to Buy Frontage’s Bioanalysis and DMPK Businesses for About $470 Million
Merger & Acquisitions Healthcare & Pharmaceuticals News

Charles River Frontage Acquisition: Charles River Laboratories to Buy Frontage’s Bioanalysis and DMPK Businesses for About $470 Million

9 November 20269 November 2026
BiotechReality Business Intelligence Desk
Eli Lilly and Company’s Foundayo Sleep Apnea Phase 3 ATTAIN-OSA Results Show Up to 44% Fewer Breathing Interruptions
Clinical Data Clinical Trials Healthcare & Pharmaceuticals News Weight-loss Drugs

Eli Lilly and Company’s Foundayo Sleep Apnea Phase 3 ATTAIN-OSA Results Show Up to 44% Fewer Breathing Interruptions

9 November 20269 November 2026
Clinical Trials & Data Desk
Advertisement
BiotechReality JobFinder

  • Global Clinical Supply Business Support Coordinator – Pfizer, Makati
    9 November 2026
  • Senior Product Analyst – Novartis, India
    25 October 2026
  • Rare Disease Medical Science Liaison (MSL) – Amgen, Japan
    20 October 2026
  • Clinical Project Management Director – IQVIA
    16 October 2026
  • Senior Manager, Global Digital Marketing – Lonza
    11 October 2026

BiotechReality Shots Weekly Newsletter

Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
SciRealityPress BiotechReality

A SciRealityPress Associate

Contents in the website is licensed under CC BY-NC 4.0

Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary. All trademarked names mentioned in the contents belongs to their respective owners. Stock exchange data providing by Stockdio

SciRealityPress © 2026
  • About
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Platform Status
  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
  • linkedin
  • facebook
  • instagram
  • twitter